ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 102 filers reported holding ORIC PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $905,000 | -59.8% | 176,217 | +15.2% | 0.20% | -59.3% |
Q4 2021 | $2,249,000 | +103.7% | 153,000 | +188.7% | 0.50% | +88.3% |
Q3 2021 | $1,104,000 | +17.7% | 53,000 | 0.0% | 0.27% | +7.3% |
Q2 2021 | $938,000 | -27.7% | 53,000 | 0.0% | 0.25% | -27.7% |
Q1 2021 | $1,298,000 | -27.4% | 53,000 | 0.0% | 0.34% | -29.9% |
Q4 2020 | $1,789,000 | – | 53,000 | – | 0.49% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 602,272 | $2,698,000 | 8.92% |
Column Group LLC | 3,568,181 | $15,985,000 | 3.40% |
Euclidean Capital LLC | 747,550 | $3,349,000 | 2.85% |
Invus Financial Advisors, LLC | 1,007,575 | $4,514,000 | 2.72% |
SILVERARC CAPITAL MANAGEMENT, LLC | 1,082,304 | $4,849,000 | 1.49% |
Monaco Asset Management SAM | 364,741 | $1,634,000 | 0.71% |
EcoR1 Capital, LLC | 3,418,068 | $15,313,000 | 0.53% |
DAFNA Capital Management LLC | 415,926 | $1,863,000 | 0.51% |
Boxer Capital, LLC | 1,054,000 | $4,722,000 | 0.30% |
Casdin Capital, LLC | 601,515 | $2,695,000 | 0.23% |